Drug
Tolnaftate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Drug Administered At Inappropriate Site | 13 | 19.7 | 19.9 | signal |
| 2 | Blood Potassium Increased | 14 | 14.0 | 14.1 | signal |
| 3 | Deformity | 7 | 12.1 | 12.2 | signal |
| 4 | Red Blood Cell Sedimentation Rate Increased | 8 | 11.7 | 11.8 | signal |
| 5 | Abasia | 18 | 11.7 | 11.8 | signal |
| 6 | Hepatic Cirrhosis | 13 | 11.3 | 11.4 | signal |
| 7 | Anhedonia | 16 | 9.8 | 9.9 | signal |
| 8 | Application Site Pain | 13 | 9.6 | 9.7 | signal |
| 9 | Skin Lesion | 15 | 8.9 | 9.0 | signal |
| 10 | Economic Problem | 8 | 8.4 | 8.5 | signal |
| 11 | Body Height Decreased | 5 | 7.5 | 7.5 | signal |
| 12 | Hip Arthroplasty | 7 | 7.5 | 7.5 | signal |
| 13 | Tooth Disorder | 10 | 7.3 | 7.3 | signal |
| 14 | Impaired Driving Ability | 5 | 7.1 | 7.1 | signal |
| 15 | Application Site Erythema | 11 | 6.8 | 6.8 | signal |
| 16 | Glycosylated Haemoglobin Increased | 10 | 6.4 | 6.5 | signal |
| 17 | Expired Product Administered | 12 | 5.9 | 5.9 | signal |
| 18 | Disability | 7 | 5.7 | 5.8 | signal |
| 19 | Incorrect Drug Administration Duration | 10 | 5.7 | 5.7 | signal |
| 20 | Drug Prescribing Error | 6 | 5.0 | 5.0 | signal |
| 21 | Parkinsonism | 3 | 5.0 | 5.0 | signal |
| 22 | Skin Irritation | 14 | 4.9 | 5.0 | signal |
| 23 | Inflammatory Bowel Disease | 3 | 4.9 | 5.0 | signal |
| 24 | Anorexia | 3 | 3.7 | 3.7 | no signal |
| 25 | Psoriatic Arthropathy | 9 | 3.6 | 3.6 | signal |
| 26 | Application Site Rash | 3 | 3.5 | 3.5 | no signal |
| 27 | Prostatic Specific Antigen Increased | 3 | 3.5 | 3.5 | no signal |
| 28 | Drug Effect Decreased | 11 | 3.3 | 3.3 | signal |
| 29 | Application Site Pruritus | 4 | 2.9 | 2.9 | no signal |
| 30 | Product Administered At Inappropriate Site | 3 | 2.7 | 2.7 | no signal |
| 31 | Gastric Cancer | 4 | 2.5 | 2.5 | no signal |
| 32 | Intentional Drug Misuse | 3 | 2.3 | 2.3 | no signal |
| 33 | Tardive Dyskinesia | 4 | 2.3 | 2.3 | no signal |
| 34 | Accidental Exposure To Product | 12 | 1.9 | 2.0 | no signal |
| 35 | Device Dislocation | 5 | 1.9 | 1.9 | no signal |
| 36 | Pharmaceutical Product Complaint | 3 | 1.8 | 1.8 | no signal |
| 37 | Breast Cancer Female | 3 | 1.8 | 1.8 | no signal |
| 38 | Gynaecomastia | 3 | 1.6 | 1.6 | no signal |